Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Sorin and Greatbatch collaborate to develop CRM systems

Sorin : 20 May, 2008  (Company News)
The Sorin Group and Greatbatch is to collaborate to enable Greatbatch's eM-able technology to be use in the Sorin Group's future cardiac rhythm management (CRM) systems.
Catherine Picard, vice-president of R and D at Sorin Group said, 'We are very excited by the opportunity to leverage Greatbatch's eM-able technology to accelerate our MRI programme and deliver MRI conditional systems to patients and physicians worldwide in the shortest possible time.'

Many patients implanted with a pacemaker or a defibrillator (ICD) cannot take advantage of an MRI scan, because energy from this life-saving technology can change how a device controls the heart, damages the device or injures the heart tissue surrounding it.

MRI conditional approved devices are critical to allow patients with active implantable medical devices (AIMDs) to safely have an MRI for diagnostic evaluation.

'As we see more patients receive AIMD's the need for MRI conditional devices will continue to grow, said Mauricio Arellano, senior vice president of Greatbatch's CRM and Neuromodulation business. 'This potential partnership with Sorin Group would meet that demand by securing our technology in their next generation devices.'

John Farrell, vice-president of Greatbatch's Therapy Delivery business, added, 'There has been extensive research and technology development on eM-able, and we are excited to get moving on our first commercialisation programme that will bring the technology to market, improving patient safety.'
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo